Silent Advanced Moyamoya Disease in an Asymptomatic Elderly Patient: A Rare Case Report
DOI:
https://doi.org/10.22225/amj.6.2.2026.470-476Keywords:
Moyamoya disease, cerebral collateral circulation, Digital Subtraction Angiography, silent cerebrovascular diseaseAbstract
Abstract
Background: Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive non-atherosclerotic steno-occlusion of the terminal portion of the internal carotid artery (ICA) and its major branches, leading to the formation of abnormal collateral vessels. The diagnosis of MMD is generally established based on the evaluation of neurological symptoms and brain imaging findings. However, asymptomatic MMD in elderly patients is rare and is often detected incidentally.
Case Report: A 77-year-old man presented to the neurology outpatient clinic for a routine health evaluation. He had a history of hypertension and was compliant with regular antihypertensive medication, with no reported neurological symptoms. Neurological examination revealed no abnormalities. Brain magnetic resonance imaging (MRI) demonstrated occlusion of the M1 segment of the middle cerebral artery. Digital Subtraction Angiography (DSA) showed total occlusion of the left middle cerebral artery (M1 segment) with collateral circulation from the anterior cerebral artery, posterior cerebral artery, and superficial temporal artery, without delayed arterial filling, consistent with advanced-stage MMD (stage V–VI). The patient was managed conservatively with antiplatelet therapy, statins, and control of vascular risk factors.
Discussion: The asymptomatic clinical presentation in advanced stages may be attributed to the development of adequate collateral circulation capable of maintaining cerebral perfusion. This hemodynamic compensatory mechanism may allow some patients to remain free of neurological deficits despite occlusion of major cerebral arteries.
Conclusion: This case highlights that MMD can remain asymptomatic in elderly patients. Imaging modalities such as MRI and DSA play a crucial role in detecting occult cerebrovascular abnormalities and enabling appropriate monitoring and prevention of future cerebrovascular complications.
Keywords: Moyamoya disease, cerebral collateral circulation, Digital Subtraction Angiography, silent cerebrovascular disease.
References
References
1. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056-1066. doi:10.1016/S1474-4422(08)70240-0.
2. Lee SU, Oh CW, Kwon OK, Bang JS, Ban SP, Byoun HS, Kim T. Surgical treatment of adult moyamoya disease. Curr Treat Options Neurol. 2018;20(6):22. doi:10.1007/s11940-018-0511-8.
3. Muljadi R, Koesbandono, Pratama TA, Octavius GS. Moyamoya disease and moyamoya syndrome: A case series from multicentre private hospitals in Indonesia. Neurocir Engl Ed. 2025;36(3):151-160. doi:10.1016/j.neucie.2024.11.008.
4. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226-1237. doi:10.1056/NEJMra0804622.
5. Gonzalez NR, Amin-Hanjani S, Bang OY, Coffey C, Du R, Fierstra J, Fraser JF, Kuroda S, Tietjen GE, Yaghi S, et al. Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54(12):e465-e479. doi:10.1161/STR.0000000000000443.
6. Ge P, Ye X, Liu X, Deng X, Zhang D, Wang R. Clinical features, surgical treatment, and long-term outcome in elderly patients with moyamoya disease. World Neurosurg. 2017;99:590-598. doi:10.1016/j.wneu.2016.12.028.
7. Rutman AM, Wangaryattawanich P, Aksakal M, Mossa-Basha M. Incidental vascular findings on brain magnetic resonance angiography. Br J Radiol. 2023;96(1142):20220135. doi:10.1259/bjr.20220135.
8. Du L, Jiang H, Li J, Duan T, Zhou C, Yan F. Imaging methods for surgical revascularization in patients with moyamoya disease: an updated review. Neurosurg Rev. 2022;45(1):343-356. doi:10.1007/s10143-021-01596-0.
9. Tian B, Jiang Y, Kang Q, et al. Comparative study of 4D CTA and DSA for vascular assessment in moyamoya disease. Clin Imaging. 2018;48:74-78. doi:10.1016/j.clinimag.2017.10.005.
10. Zhang H, Zheng L, Feng L: Epidemiology, diagnosis and treatment of Moyamoya disease . Exp Ther Med. 2019, 17:1977-84. doi:10.3892/etm.2019.7198
11. Bonasia S, Ciccio G, Robert T, et al. Angiographic analysis of natural anastomoses between the posterior and anterior cerebral arteries in moyamoya disease and syndrome. AJNR Am J Neuroradiol. 2019 Dec;40(12):2066–2072. doi: 10.3174/ajnr.A6291.
12. Liu J, Zhao Y, Zhang D, et al. Physiological and pathophysiological mechanisms of angiogenesis and inflammation in moyamoya angiopathy. Front Neurol. 2023;14:661611. doi:10.3389/fneur.2023.661611.
13. Ye F, et al. Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease. Front Neurol. 2021;11:608000. doi:10.3389/fneur.2020.608000.
14. Pang CH, Cho WS, Kang HS, Kim JE. Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease. Sci Rep. 2021;11(1):19367. doi:10.1038/s41598-021-99009-1.
15. Luo Y, Cao Z, Ye H, Wu S, Sun X. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study. J Neurol. 2023;270(8):3876-3884. doi:10.1007/s00415-023-11702-5.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Putu Ayu Dyah Meita Wulandari, Shahifa Audy Rahima, I Gusti Agung Ayu Pramasinthya Aguseny Yudana, Yoanes Gondowardaja, Desie Yuliani
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
